Bernard Hirschel
Bernard Hirschel
Unknown affiliation
Verified email at
Cited by
Cited by
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study
A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ...
Gastroenterology 138 (4), 1338-1345. e7, 2010
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
G Greub, B Ledergerber, M Battegay, P Grob, L Perrin, H Furrer, ...
The Lancet 356 (9244), 1800-1805, 2000
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
B Ledergerber, M Egger, M Opravil, A Telenti, B Hirschel, M Battegay, ...
The Lancet 353 (9156), 863-868, 1999
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study
M Egger, B Hirschel, P Francioli, P Sudre, M Wirz, M Flepp, M Rickenbach, ...
Bmj 315 (7117), 1194-1199, 1997
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
S Simioni, M Cavassini, JM Annoni, AR Abraham, I Bourquin, V Schiffer, ...
Aids 24 (9), 1243-1250, 2010
AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study
B Ledergerber, M Egger, V Erard, R Weber, B Hirschel, H Furrer, ...
Jama 282 (23), 2220-2226, 1999
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
GR Kaufmann, L Perrin, G Pantaleo, M Opravil, H Furrer, A Telenti, ...
Archives of internal medicine 163 (18), 2187-2195, 2003
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
J Fellay, B Ledergerber, E Bernasconi, H Furrer, M Battegay, B Hirschel, ...
The Lancet 358 (9290), 1322-1327, 2001
Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle
P Vernazza, B Hirschel, E Bernasconi, M Flepp
Bulletin des médecins suisses| Schweizerische Ärztezeitung| Bollettino dei …, 2008
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
G Fätkenheuer, M Nelson, A Lazzarin, I Konourina, AIM Hoepelman, ...
New England Journal of Medicine 359 (14), 1442-1455, 2008
Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to< 500 Cells/µL in HIV Type 1—Infected Individuals Receiving Potent Antiretroviral Therapy
GR Kaufmann, H Furrer, B Ledergerber, L Perrin, M Opravil, P Vernazza, ...
Clinical infectious diseases 41 (3), 361-372, 2005
Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen
N Sachsenberg, AS Perelson, S Yerly, GA Schockmel, D Leduc, ...
The Journal of experimental medicine 187 (8), 1295-1303, 1998
HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study.
M Opravil, M Pechere, R Speich, HI Joller-Jemelka, R Jenni, EW Russi, ...
American journal of respiratory and critical care medicine 155 (3), 990-995, 1997
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1–infected adults treated with combination antiretroviral therapy
H Furrer, M Egger, M Opravil, E Bernasconi, B Hirschel, M Battegay, ...
New England Journal of Medicine 340 (17), 1301-1306, 1999
A controlled trial of zidovudine in primary human immunodeficiency virus infection
S Kinloch-de Loës, BJ Hirschel, B Hoen, DA Cooper, B Tindall, A Carr, ...
New England Journal of Medicine 333 (7), 408-413, 1995
Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects
P Lorenzi, VM Spicher, B Laubereau, B Hirschel, C Kind, C Rudin, O Irion, ...
Aids 12 (18), F241-F247, 1998
HIV rebounds from latently infected cells, rather than from continuing low-level replication
B Joos, M Fischer, H Kuster, SK Pillai, JK Wong, J Böni, B Hirschel, ...
Proceedings of the National Academy of Sciences 105 (43), 16725-16730, 2008
The system can't perform the operation now. Try again later.
Articles 1–20